Model Number 172020-CASJ |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Thrombus (2101)
|
Event Date 07/14/2019 |
Event Type
Injury
|
Manufacturer Narrative
|
The lot number was not provided; therefore, a search for production-related ncrs could not be performed.The stent was implanted in the patient and the remainder of the device was not returned to the manufacturer; therefore, a product analysis could not be performed.The root cause is unknown.The instructions for use (ifu) identifies thrombus as a potential complication associated with use of the device.
|
|
Event Description
|
It was reported that a patient enrolled in the lepi clinical trial was treated with an lvis stent for a recanalized saccular acomm artery aneurysm that had never ruptured and was previously treated with embolization coils.During the procedure, angiographic imaged demonstrated multiple small thrombus in the stent.Circulation in the anterior cerebral artery was still maintained.An iv bolus of reopro (25mg/kg) was administered intravenously.The patient's outcome was reported to be "resolved without sequelae on the same day." the patient was reported to be asymptomatic and was discharged with a mrs=0.The patient will continue to be monitored per clinical trial protocol.
|
|
Manufacturer Narrative
|
A search for non-conformances associated with this part/lot number combination did not reveal any production-related issues relevant to the complaint that occurred during manufacturing of the device.B5: additional information: the procedure report was received from the clinical site on (b)(6) 2019.Additional details indicate that the a-com aneurysm had a wide neck and stent-assisted coiling was performed, aided by the implantation of an lvis jr.Stent.The patient was placed on dual antiplatelet therapy for 3 months, followed by kargegic alone for up to one year.
|
|
Search Alerts/Recalls
|